SCHEMBL919037

SCHEMBL919037

CCC=COO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14007282 1.00
SCHEMBL5410848 0.75
SCHEMBL10625875 0.75
SCHEMBL28643093 0.72
SCHEMBL905351 0.72
SCHEMBL75982 0.72
SCHEMBL28643095 0.72
SCHEMBL436544 0.69
SCHEMBL892030 0.69
SCHEMBL12573994 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12414934-B2 Combination therapies Aardvark Therapeutics, Inc. (US) 2025-09-16 US disclosed
US-12370352-B2 Nasal and ophthalmic delivery of aqueous corticosteroid solutions CYDEX PHARMACEUTICALS, INC. (US) 2025-07-29 US disclosed
US-12329739-B2 Isoflavonoid compounds and methods for the treatment of cancer Aardvark Therapeutic, Inc. (US) 2025-06-17 US disclosed
US-12318364-B2 Isoflavonoid compositions and methods for the treatment of cancer Aardvark Therapeutics, Inc. (US) 2025-06-03 US disclosed
US-20250001727-A1 LAMINATE AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2025-01-02 US disclosed
US-12103292-B2 Laminate and image display device FUJIFILM CORPORATION (JP) 2024-10-01 US disclosed
WO-2024137472-A2 COMBINATION THERAPIES MEI PHARMA, INC. (US) 2024-06-27 WO disclosed
US-20240165073-A1 ISOFLAVONOID COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER Aardvark Therapeutics, Inc. 2024-05-23 US disclosed
US-20230372287-A1 ISOFLAVONOID COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER Aardvark Therapeutics, Inc. 2023-11-23 US disclosed
US-11723893-B2 Isoflavonoid compositions and methods for the treatment of cancer MEI PHARMA, INC. (US) 2023-08-15 US disclosed
EP-1425311-A4 CYCLODEXTRIN SULFONATES, GUEST INCLUSION COMPLEXES, METHODS OF MAKING THE SAME AND RELATED MATERIALS EASTMAN CHEM CO (US) 2004-12-01 EP disclosed
CN-1550505-A Cyclodextrin ethers �Ϻ���ͨ��ѧ 2004-12-01 CN disclosed
EP-1425311-A2 CYCLODEXTRIN SULFONATES, GUEST INCLUSION COMPLEXES, METHODS OF MAKING THE SAME AND RELATED MATERIALS EASTMAN CHEMICAL COMPANY (US) 2004-06-09 EP disclosed
US-20040054164-A1 Cyclodextrin sulfonates, guest inclusion complexes, methods of making the same and related materials EASTMAN CHEMICAL COMPANY (US) 2004-03-18 US disclosed
US-6610671-B2 Cyclodextrin derivatives for use in cosmetics, pharmacolog, cosmetic, or nutrients EASTMAN CHEMICAL COMPANY 2003-08-26 US disclosed
US-20020128468-A1 Cyclodextrin sulfonates, guest inclusion complexes methods of making the same and related materials BUCHANAN CHARLES M (US) 2002-09-12 US disclosed
WO-2002055562-A2 CYCLODEXTRIN SULFONATES, GUEST INCLUSION COMPLEXES, METHODS OF MAKING THE SAME AND RELATED MATERIALS EASTMAN CHEM CO (US) 2002-07-18 WO disclosed
EP-0520608-B1 Silicones which contain lateral peripheral vinyl ether groups crosslinkable by cationic photoinitiators and their application for coatings and antiadhesive products for paper DOW CORNING (US) 1996-03-06 EP disclosed
US-5208312-A Release agents DOW CORNING CORPORATION (US) 1993-05-04 US disclosed
EP-0520608-A1 Silicones which contain lateral peripheral vinyl ether groups crosslinkable by cationic photoinitiators and their application for coatings and antiadhesive products for paper DOW CORNING CORPORATION (US) 1992-12-30 EP disclosed